alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
DLM 4000.25, Volume 2, November 26, 2019

Change 13

AP8.36-1 APPENDIX 8.36

AP8.36. APPENDIX 8.36

DISPOSITION INSTRUCTIONS DELAY STATUS

(MATERIEL RETURNS PROGRAM)

FIELD LEGEND

RECORD

POSITION(S) ENTRY AND INSTRUCTIONS

Document Identifier Code 1-3 Enter DIC FTD.

Routing Identifier Code 4-6 Enter the RIC of the inventory control 

point (ICP)/integrated material manager 

(IMM) or Defense Automatic Addressing 

System (DAAS) facility furnishing the 

status.

Media and Status 7 Enter data as contained in DIC FTE or 

DIC FTF.

Stock Number 8-22 Enter data as contained in DIC FTE or 

DIC FTF.

Unit of Issue 23-24 Enter data as contained in DIC FTE or 

DIC FTF.

Quantity 25-29 a. Enter the quantity.

b. For ammunition and ammunition 

related items only (items in Federal supply 

group (FSG) 13 and for Federal supply 

classification (FSC) 1410, 1420, 1427, 

1440, 5330, 5865, 6810 or 8140), enter an 

M in rp 29 to express in thousands any 

quantity exceeding 99,999. Example: 

Express a quantity of 1,950,000 as 

1950M (1950 in rp 25-28 and an M in rp 

29).

Document Number 30-43 Enter data as contained in DIC FTE or 

DIC FTF.

Suffix 44 Enter data as contained in DIC FTE or 

DIC FTF.

Supplementary Address 45-50 Enter data as contained in DIC FTE or 

DIC FTF.

Signal 51 Enter data as contained in DIC FTE or 

DIC FTF.
DLM 4000.25, Volume 2, November 26, 2019

Change 13

AP8.36-2 APPENDIX 8.36

FIELD LEGEND

RECORD

POSITION(S) ENTRY AND INSTRUCTIONS

Fund 52-53 Enter data as contained in DIC FTE or 

DIC FTF.

Blank 54-56 Enter data as contained in DIC FTE or 

DIC FTF.

Project 57-59 Enter data as contained in DIC FTE or 

DIC FTF.

Blank 60-61 Leave blank.

Action Date 62-64 Enter the ordinal day of document 

preparation.

Status 65-66 Enter the status code.

Routing Identifier 67-69 Enter data as contained in DIC FTE or 

DIC FTF.

Expected Reply Date 70-73 Enter the ordinal day disposition 

instructions from the ICP may be 

expected.

Blank 74-80 Leave blank.
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________ No. 19

- 12407 Non

- Argument Calendar

________________________ D.C. Docket No. 6:18

- cr

- 00166

- PGB

- LRH

- 1

UNITED STATES OF AMERICA,

Plaintiff

- Appellee,

versus
CATR ELL IVORY, a.k.a. Woosa, a.k.a. Woo,

Defendant

- Appellant.

________________________ Appeal from the United States District Court for the Middle District of Florida

________________________ ( April 16, 2020 )
Before ED CARNES , Chief Judge, BRANCH and FAY , Circuit Judges.

PER CURIAM:

Case: 19-12407 Date Filed: 04/16/2020 Page: 1 of 22 Thomas H. Dale, appointed counsel for Catrell Ivory in this direct criminal appeal, has moved to withdraw from further representation of the appe llant and filed a brief pursuant to Anders v. California , 386 U.S. 738 (1967). Ivory has filed a responsive brief. Because independent examination of the entire record reveals no arguable issues of merit, counsel’s motion to withdraw is GRANTED , and Ivory ’s conviction s and sentence s are AFFIRMED

.

Case: 19-12407 Date Filed: 04/16/2020 Page: 2 of 2
<PAGE>
                                                                      EXHIBIT 24
 
                             DIRECTORS AND OFFICERS
                               POWER OF ATTORNEY
 
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
 
    RE:  Jo-Ann Stores, Inc.
         Commission File No. 1-6695
         1934 Act Filings on Form 10-K
         For Fiscal Year Ended January 30, 1999
 
Gentlemen:
 
The above Company is the issuer of securities registered under Section 12 of the
Securities Exchange Act of 1934 (the "Act"). Each of the persons signing his or
her name below confirms, as of the date appearing opposite his or her signature,
that Alan Rosskamm, Brian P. Carney, and each of them, are authorized on his or
her behalf to sign and to submit to the Securities and Exchange Commission such
filings on Form 10-K as are required by the Act. Each person so signing also
confirms the authority of Alan Rosskamm, Brian P. Carney, and each of them, to
do and perform on his or her behalf, any and all acts and things requisite or
necessary to assure compliance by the signing person with the Form 10-K filing
requirements. The authority confirmed herein shall remain in effect as to each
person signing his or her name below until such time as the Commission shall
receive from such person a written communication terminating or modifying the
authority.
<TABLE>
<CAPTION>
                                           DATE
                                    ------------------
<C>                                 <S>
        /s/ ALAN ROSSKAMM
   ---------------------------      April 16, 1999
          Alan Rosskamm
 
       /s/ BRIAN P. CARNEY
   ---------------------------      April 16, 1999
         Brian P. Carney
 
        /s/ BETTY ROSSKAMM
   ---------------------------      April 16, 1999
          Betty Rosskamm
 
        /s/ ALMA ZIMMERMAN
   ---------------------------      April 16, 1999
          Alma Zimmerman
 
<CAPTION>
                                           DATE
                                    ------------------
<C>                                 <S>
 
         /s/ SCOTT COWEN
   ---------------------------      April 15, 1999
           Scott Cowen
 
         /s/ FRANK NEWMAN
   ---------------------------      April 15, 1999
           Frank Newman
 
         /s/ IRA GUMBERG
   ---------------------------      April 15, 1999
           Ira Gumberg
 
         /s/ GREGG SEARLE
   ---------------------------      April 15, 1999
           Gregg Searle
 
         /s/ DEBRA WALKER
   ---------------------------      April 15, 1999
           Debra Walker
</TABLE>
Exhibit 32.1


Written Statement of the Chief Executive Officer


Pursuant to 18 U.S.C. §1350


Solely for the purposes of complying with 18 U.S.C. §1350, I, the undersigned Chief Executive Officer of Regency Centers Corporation , hereby certify, based on my knowledge , that the Quarterly Report on Form 10-Q of Regency Centers Corporation for the quarter ended June 30, 2011 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Regency Centers Corporation.


Date: August 5, 2011





/s/ Martin E. Stein, Jr.Martin E. Stein, Jr.Chief Executive Officer
Exhibit 31.1  **CERTIFICATION OF CHIEF EXECUTIVE OFFICER**I, John P. Mitola, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Electric City Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3. Based on my knowledge, the financial statements and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the Registrant as of, and for, the periodspresented in this report;  4. The Registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the Registrant and have: a. designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the Registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;  b. evaluated the effectiveness of the Registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and  c. disclosed in this report any change in the Registrant’s internalcontrol over financial reporting that occurred during the Registrant’s most recentfiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annualreport) that has materially affected, or is reasonably likely to materially affect,the Registrant’s internal control over financial reporting; and 5. The Registrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the Registrant’sauditors and the Audit Committee of the Registrant’s Board of Directors (or personsperforming the equivalent function): a. all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likelyto adversely affect the Registrant’s ability to record, process, summarize andreport financial information; and  b. any fraud, whether or not material, that involves management or otheremployees who have a significant role in the Registrant’s internal controls overfinancial reporting.   /s/ John P. Mitola  John P. Mitola  Chief Executive Officer  November 10, 2005  
-31-
```

[Federal Register Volume 79, Number 249 (Tuesday, December 30, 2014)]
[Notices]
[Page 78434]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-30476]

-----------------------------------------------------------------------

EXPORT-IMPORT BANK

[Public Notice: 2014-0054]

Application for Final Commitment for a Long-Term Loan or 
Financial Guarantee in Excess of $100 Million: AP088920XX

AGENCY: Export-Import Bank of the United States.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This Notice is to inform the public, in accordance with 
Section 3(c)(10) of the Charter of the Export-Import Bank of the United 
States (``Ex-Im Bank''), that Ex-Im Bank has received an application 
for final commitment for a long-term loan or financial guarantee in 
excess of $100 million (as calculated in accordance with Section 
3(c)(10) of the Charter).
    Comments received within the comment period specified below will be 
presented to the Ex-Im Bank Board of Directors prior to final action on 
this Transaction.

DATES: Comments must be received on or before January 26, 2015 to be 
assured of consideration before final consideration of the transaction 
by the Board of Directors of Ex-Im Bank.

ADDRESSES: Comments may be submitted through Regulations.gov at 
WWW.REGULATIONS.GOV. To submit a comment, enter EIB-2014-0054 under the 
heading ``Enter Keyword or ID'' and select Search. Follow the 
instructions provided at the Submit a Comment screen. Please include 
your name, company name (if any) and EIB-2014-0054 on any attached 
document.
    Reference: AP088941XX.
    Purpose and Use:
    Brief description of the purpose of the transaction:
    To support the export of U.S.-manufactured commercial aircraft to 
Turkey.
    Brief non-proprietary description of the anticipated use of the 
items being exported:
    To be used for passenger air service between Turkey and other 
countries. To the extent that Ex-Im Bank is reasonably aware, the items 
being exported are not expected to produce exports or provide services 
in competition with the exportation of goods or provision of services 
by a United States industry.
    Parties:
    Principal Suppliers: The Boeing Company.
    Obligor: Turk Hava Yollari A.O.
    Guarantor(s): N/A.
    Description of Items Being Exported:
    Boeing 777 aircraft.
    Information on Decision: Information on the final decision for this 
transaction will be available in the ``Summary Minutes of Meetings of 
Board of Directors'' on http://exim.gov/newsandevents/boardmeetings/board/.
    Confidential Information: Please note that this notice does not 
include confidential or proprietary business information; information 
which, if disclosed, would violate the Trade Secrets Act; or 
information which would jeopardize jobs in the United States by 
supplying information that competitors could use to compete with 
companies in the United States.

Lloyd Ellis,
Program Specialist, Office of the General Counsel.
[FR Doc. 2014-30476 Filed 12-29-14; 8:45 am]
BILLING CODE 6690-01-P
```
Exhibit 32.02

Certification of Chief Financial Officer Pursuant to

18 U.S.C. Section 1350

and Securities Exchange Act Rule 13a-14(b)

In
connection with the Quarterly Report of Concur Technologies, Inc. (Concur) on Form 10-Q for the quarter ended March 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, John
F. Adair, as Chief Financial Officer of Concur, hereby certify, pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b), that to my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
| | --- | ------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Concur.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------

Dated: May 7, 2009



By

/s/ John F. AdairJohn F. AdairChief Financial Officer


This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
and shall not be deemed to be filed by Concur for purposes of Section 18 of the Securities Exchange Act of 1934. This certification is not to be incorporated by reference into any filing of Concur under the Securities Act of 1933, as amended,
or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this report), irrespective of any general incorporation language contained in such filing.
EXHIBIT 32.1
                                                                    ------------



                              FAB INDUSTRIES, INC.

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Fab Industries, Inc. (the "Company") on
Form 10-K for the period ending November 29, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Samson Bitensky,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

         (1)      The Report fully complies with the requirements of section
         13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
         all material respects, the financial condition and results of
         operations of the Company.



By: /s/ Samson Bitensky
    --------------------------

Samson Bitensky
Chief Executive Officer
February __, 2004
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Corinthian Colleges, Inc. (the
Company) on Form 10-Q for the period ended December 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Jack D. Massimino, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                 |  |  |  |                                                                                      
|---------------- |  |  |  | -------------------------------------------------------------------------------------
|                 |  | 
|February 9, 2006 |  |  |  | /s/    JACK D. MASSIMINO                                                             
|                 |  |  |  | Jack D. Massimino President and Chief Executive Officer (Principal Executive Officer)
UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

_____________________

No. 97-40947

_____________________

SUSAN WILSON,

Plaintiff-Appellant/Cross-Appellee,

versus

CITY OF PLANO, TEXAS,

Defendant-Appellee/Cross-Appellant.

_______________________________________________________

Appeals from the United States District Court

for the Eastern District of Texas

_______________________________________________________

January 7, 1999

ON REMAND FROM THE SUPREME COURT

OF THE UNITED STATES

Before WIENER, BARKSDALE, and EMILIO M. GARZA, Circuit Judges.

PER CURIAM:

The Supreme Court vacated the judgment and remanded this case

to our court for further consideration in the light of Faragher v.

City of Boca Raton, 524 U.S. ___, 118 S. Ct. 2275 (1998), and

Burlington Industries, Inc. v. Ellerth, 524 U.S. ___, 118 S. Ct.

2257 (1998). Concluding, in the light of those cases, that this

case presents issues that the parties should be permitted to

develop further, including through additional discovery and

supplemented motions for summary judgment, but without in any way
- 2 -

intimating our view as to the merits of the claims by Susan Wilson,

this case is REMANDED to the district court for further

proceedings.

 REMANDED
No. 10-10779.

#### Larry Gene Tilcock, Petitioner v. Gregory Smith, Warden.

565 U.S. 849, 132 S. Ct. 171,

181 L. Ed. 2d 83,

2011 U.S. LEXIS 6261.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
National Center for Emerging and Zoonotic Infectious Diseases

Orthopoxvirus Work Group Update

ACIP Meeting

November 3, 2021

Pablo Sanchez, MD

Chair, ACIP Orthopoxvirus WG
Work Group Members

ACIP Members

Pablo Sánchez

Beth Bell

Wilbur Chen

Ex Officio Members

DoD- Jay Montgomery

DoD-Bryan Schumacher

FDA- Sixun Yang, Clement 

Meseda & Alonzo García

NIH- Mark Challberg

Liaison Representatives

ACOG- Howard Minkoff

NACCHO- Jee Kim

NACI- April Killikelly

SHEA- David Weber

Invited Consultants

HHS/BARDA- Mike Merchlinksy, Amanda 

Zarrabian, and Ramya Natarajan

NIH- Heike Bailin

Subject Matter Expert: Stuart Isaacs

APHL- Jafar Razeq
CDC Contributors

Subject Matter Expert- Inger Damon 

Immunization Safety OfficeMike McNeil

Regulatory Affairs: Yon Yu & 

Lisa Hesse

NIOSH: Marie de Perio

Drug Services: Julian Jolly

Division of Healthcare Quality 

Promotion- David Kuhar

Laboratory Response NetworkJulie Villanueva 

Orthopoxvirus Work Group leads –

Agam Rao & Brett Petersen
Most recent discussions

▪ September 29th ACIP meeting

– Background information important to understanding Evidence to 

Recommendations frameworks (EtRs)

– EtRs for five policy questions for JYNNEOS®

▪ WG discussions since September meeting

– Clinical guidance for use of JYNNEOS® (including contraindications, precautions / 

warnings)

– Wording of proposed recommendations
Today’s presentations

▪ Clinical guidance for use of JYNNEOS®: Dr. Brett Petersen

▪ Summary of work group considerations and proposed policy options: 

Agam Rao

---------------------------------------------------------------

▪ Orthopoxviruses Vaccine Vote
Anticipated timeline

-GRADE & EtR

September 2021 November 2021 Early/Mid 2022

-Clinical guidance

-Vote

-MMWR publication

-Recommendations become 

official
For more information, contact CDC

1-800-CDC-INFO (232-4636)

TTY: 1-888-232-6348 www.cdc.gov

The findings and conclusions in this report are those of the authors and do not necessarily represent the 

official position of the Centers for Disease Control and Prevention.

Thank you!
Meeting Summary

November 19, 2015

Profenofos Registration Review

Meeting Between EPA/OPP and Syngenta

Meeting participants: Chuck Levey (Syngenta Crop Protection); Christina Scheltema, Tracy 

Perry, and Kelly Sherman (EPA/OPP/Pesticide Re-evaluation Division); Charles (Billy) Smith 

(Health Effects Division)

Summary: Members of the OPP profenofos team met briefly with Syngenta to discuss the 

ongoing registration review of the insecticide profenofos. The preliminary risk assessments for 

this organophosphate published on September 24, 2015, and EPA is currently accepting public 

comments on the assessments. The comment period will be extended for an additional 45 days.
##### 



Exhibit 31.3
 
      a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;b)
    
    Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted
accounting principles;c)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such
evaluation; andd)
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and
  a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
andb)
    
    Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
 April 12, 2006
    /s/ Ira D. KaplanIra D. KaplanChief Financial Officer
No. 10-9681.

#### Larry Eugene Jackson, Petitioner v. United States.

565 U.S. 830, 132 S. Ct. 126,

181 L. Ed. 2d 48,

2011 U.S. LEXIS 5303.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.